The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Guidelines for the diagnosis, prevention and management of osteoporosis
Open accessAbstract
Osteoporosis poses a significant public health issue. National Societies have developed Guidelines for the diagnosis and treatment of this disorder with an effort of adapting specific tools for risk assessment on the peculiar characteristics of a given population. The Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) has recently revised the previously published Guidelines on the diagnosis, riskassessment, prevention and management of primary and secondary osteoporosis. The guidelines were first drafted by a working group and then approved by the board of SIOMMMS. Subsequently they received also the endorsement of other major Scientific Societies that deal with bone metabolic disease. These recommendations are based on systematic reviews of the best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on leading experts’ experience and opinion, and on good clinical practice. The osteoporosis prevention should be based on the elimination of specific risk factors. The use of drugs registered for the treatment of osteoporosis are recommended when the benefits overcome the risk, and this is the case only when the risk of fracture is rather high as measured with variables susceptible to pharmacological effect. DeFRA (FRAX® derived fracture risk assessment) is recognized as a useful tool for easily estimate the long-term fracture risk. Several secondary forms of osteoporosis require a specific diagnostic and therapeutic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E. V., Jönsson, B., & Kanis, J. A. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0136-1 · Cited by 2,675
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Vestergaard, P. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0253-4 · Cited by 1,808
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Bilezikian, J. P., Khan, A. A., & Potts, J. T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1763 · Cited by 1,521
Sanders, K. M., Stuart, A. L., Williamson, E. J., Simpson, J. A., Kotowicz, M. A., Young, D., & Nicholson, G. C. (2010) · JAMA · doi:10.1001/jama.2010.594 · Cited by 1,381
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294 · cited 1×
“in glucocorticoid-induced osteoporosis is much higher as compared to that expected based on DXA BMD values, and rapidly decreases after treatment discontinuation (27, 28).”
ResultBilezikian, J. P., Brandi, M. L., Eastell, R., Silverberg, S. J., Udelsman, R., Marcocci, C., & Potts, J. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1413 · Cited by 1,271
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture
Janghorbani, M., Van Dam, R. M., Willett, W. C., & Hu, F. B. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm106 · Cited by 1,209
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Excess mortality following hip fracture: a systematic epidemiological review
Abrahamsen, B., van Staa, T., Ariely, R., Olson, M., & Cooper, C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0920-3 · Cited by 1,079
Alendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Self-citationA meta-analysis of prior corticosteroid use and fracture risk.
Kanis, J. A., Johansson, H., Oden, A., Johnell, O., de Laet, C., Melton, L. J., Tenenhouse, A., Reeve, J., Silman, A. J., Pols, H. A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040134 · Cited by 839
Orwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., Kaufman, J.-M., Clancy, A., & Gaich, G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.9 · Cited by 776
Self-citationIncidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed Population
Yeh, M. W., Ituarte, P. H. G., Zhou, H. C., Nishimoto, S., Amy Liu, I.-L., Harari, A., Haigh, P. I., & Adams, A. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4022 · Cited by 742
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3045 · Cited by 611
Guidelines for Preventing and Treating Vitamin D Deficiency and Insufficiency Revisited
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2601 · Cited by 596
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Self-citationBone health in cancer patients: ESMO Clinical Practice Guidelines
Coleman, R., Body, J. J., Aapro, M., Hadji, P., & Herrstedt, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu103 · Cited by 564
Gnant, M., Pfeiler, G., Dubsky, P. C., Hubalek, M., Greil, R., Jakesz, R., Wette, V., Balic, M., Haslbauer, F., Melbinger, E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60995-3 · Cited by 559
Interpretation and use of FRAX in clinical practice
Task Force of the FRAX Initiative, Kanis, J. A., Hans, D., Cooper, C., Baim, S., Bilezikian, J. P., Binkley, N., Cauley, J. A., Compston, J. E., Dawson-Hughes, B., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1713-z · Cited by 532
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Clarke, M. S., Sim, E. H., & Fong, K. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991.pub3 · Cited by 523
Saag, K. G., Zanchetta, J. R., Devogelaer, J., Adler, R. A., Eastell, R., See, K., Krege, J. H., Krohn, K., & Warner, M. R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24879 · Cited by 493 · cited 3×
“Teriparatide: in pazienti in terapia con glucocorticoidi, in uno studio di confronto con alendronato, protratto a 36 mesi, teriparatide è risultato più efficace di alendronato sia in termini di variazioni densitometriche (end-point primario) che di incidenza di nuove fratture vertebrali (end-point secondario) (38).”
BackgroundA family history of fracture and fracture risk: a meta-analysis
Kanis, J. A., Johansson, H., Oden, A., Johnell, O., De Laet, C., Eisman, J. A., McCloskey, E. V., Mellstrom, D., Melton, L. J., Pols, H. A. P., et al. (2004) · Bone · doi:10.1016/j.bone.2004.06.017 · Cited by 434
Committee to Review Dietary Reference Intakes for Vitamin D and Calcium
Ross, A. C., Taylor, C. L., Yaktine, A. L., & Valle, H. B. D. (2011) · Cited by 391
Fracture risk and zoledronic acid therapy in men with osteoporosis
Boonen, S., Reginster, J.-Y., Kaufman, J.-M., Lippuner, K., Zanchetta, J., Langdahl, B., Rizzoli, R., Lipschitz, S., Dimai, H. P., Witvrouw, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204061 · Cited by 359
Use of Thiazolidinediones and Fracture Risk
Meier, C., Kraenzlin, M. E., Bodmer, M., Jick, S. S., Jick, H., & Meier, C. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.820 · Cited by 355
Hippisley-Cox, J., & Coupland, C. (2012) · BMJ · doi:10.1136/bmj.e3427 · Cited by 351
Coleman, R., de Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., von Minckwitz, G., Sleeboom, H. P., Forbes, J., Barrios, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds277 · Cited by 339
Rizzoli, R., Boonen, S., Brandi, M.-L., Bruyère, O., Cooper, C., Kanis, J. A., Kaufman, J.-M., Ringe, J. D., Weryha, G., & Reginster, J.-Y. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.766162 · Cited by 330
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Loke, Y. K., Cavallazzi, R., & Singh, S. (2011) · Thorax · doi:10.1136/thx.2011.160028 · Cited by 267
Drug-induced Osteoporosis: Mechanisms and Clinical Implications
Mazziotti, G., Canalis, E., & Giustina, A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.02.028 · Cited by 262
Diamond, T. H., Higano, C. S., Smith, M. R., Guise, T. A., & Singer, F. R. (2004) · Cancer · doi:10.1002/cncr.20056 · Cited by 255
Black, D. M., Reid, I. R., Cauley, J. A., Cosman, F., Leung, P. C., Lakatos, P., Lippuner, K., Cummings, S. R., Hue, T. F., Mukhopadhyay, A., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2442 · Cited by 253
Bisphosphonates for steroid-induced osteoporosis
Allen, C. S., Yeung, J. H., Vandermeer, B., & Homik, J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001347.pub2 · Cited by 248
Diabetes mellitus and risk of hip fractures: a meta-analysis
Fan, Y., Wei, F., Lang, Y., & Liu, Y. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3279-7 · Cited by 237
Vitamin D status and response to treatment in post-menopausal osteoporosis
Adami, S., Giannini, S., Bianchi, G., Sinigaglia, L., Di Munno, O., Fiore, C. E., Minisola, S., & Rossini, M. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0650-y · Cited by 237
Self-citationCrawford, B. A. L., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021827 · Cited by 237
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives
Seibel, M. J., Cooper, M. S., & Zhou, H. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70045-7 · Cited by 226
Calcium and vitamin D for corticosteroid-induced osteoporosis
Homik, J., Suarez-Almazor, M. E., Shea, B., Cranney, A., Wells, G. A., & Tugwell, P. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000952 · Cited by 202
Dore, R. K., Cohen, S. B., Lane, N. E., Palmer, W., Shergy, W., Zhou, L., Wang, H., Tsuji, W., & Newmark, R. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.112920 · Cited by 194
Boonen, S., Orwoll, E. S., Wenderoth, D., Stoner, K. J., Eusebio, R., & Delmas, P. D. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081214 · Cited by 193
Schousboe, J. T., & DeBold, C. R. (2006) · Osteoporosis International · doi:10.1007/s00198-005-2010-5 · Cited by 186
Cancer-associated bone disease
Rizzoli, R., Body, J. J., Brandi, M. L., Cannata-Andía, J. B., Chappard, D., Maghraoui, A. E., Glüer, C.-C., Kendler, D., Napoli, N., Παπαϊωάννου, Α., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2530-3 · Cited by 163
Varenna, M., Adami, S., Rossini, M., Gatti, D., Idolazzi, L., Zucchi, F., Malavolta, N., & Sinigaglia, L. (2013) · Rheumatology · doi:10.1093/rheumatology/kes312 · Cited by 163
Self-citationLevothyroxine dose and risk of fractures in older adults: nested case-control study
Turner, M. R., Camacho, X., Fischer, H. D., Austin, P. C., Anderson, G. M., Rochon, P. A., & Lipscombe, L. L. (2011) · BMJ · doi:10.1136/bmj.d2238 · Cited by 152 · cited 1×
“La levotiroxina (in eccesso) è risultata associata ad un rischio di fratture sia nel maschio che nelle femmine (OR 1,98; CI 95% 1,15-1,76) (45).”
BackgroundDennison, E. M., Compston, J. E., Flahive, J., Siris, E. S., Gehlbach, S. H., Adachi, J. D., Boonen, S., Chapurlat, R. D., Díez‐Pérez, A., Anderson, F. A., et al. (2012) · Bone · doi:10.1016/j.bone.2012.02.639 · Cited by 148
Self-citationIncident fractures in HIV-infected individuals
Shiau, S., Broun, E. C., Arpadi, S. M., & Yin, M. T. (2013) · AIDS · doi:10.1097/qad.0b013e328361d241 · Cited by 147
Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
Pinkerton, J. V., Harvey, J. A., Lindsay, R., Pan, K., Chines, A. A., Mirkin, S., Archer, D. F., & for the SMART-5 Investigators (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1707 · Cited by 146
Parkinson's disease and osteoporosis
van den Bos, F., Speelman, A. D., Samson, M., Munneke, M., Bloem, B. R., & Verhaar, H. J. J. (2013) · Age and Ageing · doi:10.1093/ageing/afs161 · Cited by 137
Guidelines on prevention and treatment of vitamin D deficiency
Adámi, S., Romagnoli, E., Carnevale, V., Scillitani, A., Giusti, A., Rossini, M., Gatti, D., Nuti, R., & Minisola, S. (2011) · Reumatismo · doi:10.4081/reumatismo.2011.129 · Cited by 131
Self-citationLangdahl, B. L., Teglbjærg, C. S., Ho, P., Chapurlat, R. D., Czerwinski, E. J., Kendler, D. L., Reginster, J., Kivitz, A., Lewiecki, E. M., Miller, P. D., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4079 · Cited by 130
Meta-analysis: Risk of fractures with acid-suppressing medication
Kwok, C. S., Yeong, J. K.-Y., & Loke, Y. K. (2010) · Bone · doi:10.1016/j.bone.2010.12.015 · Cited by 130
Bisphosphonates for steroid induced osteoporosis
Homik, J., Cranney, A., Shea, B., Tugwell, P., Wells, G. A., Adachi, J. D., & Suarez-Almazor, M. E. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001347 · Cited by 130
Renal safety in patients treated with bisphosphonates for osteoporosis: A review
Miller, P. D., Jamal, S. A., Evenepoel, P., Eastell, R., & Boonen, S. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2058 · Cited by 124
Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review
Gunn, I. R., & Gaffney, D. (2004) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563042466802 · Cited by 109
Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men
Kaufman, J.-M., Audran, M., Bianchi, G., Braga, V., Díaz Curiel, M., Francis, R. M., Goemaere, S., Josse, R. G., Palacios, S., Ringe, J. D., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3048 · Cited by 103
Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?
Hadji, P., Gnant, M., Body, J. J., Bundred, N. J., Brufsky, A., Coleman, R., Guise, T. A., Lipton, A., & Aapro, M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.02.008 · Cited by 103
McCloskey, E. V., Vasireddy, S., Threlkeld, J., Eastaugh, J., Parry, A., Bonnet, N., Beneton, M. N. C., Kanis, J. А., & Charlesworth, D. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080515 · Cited by 100
Hodsman, A. B., Leslie, W. D., Tsang, J. F., & Gamble, G. D. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2261 · Cited by 99
Jager, P. L., Jonkman, S., Koolhaas, W., Stiekema, A., Wolffenbuttel, B. H. R., & Slart, R. H. J. A. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1293-3 · Cited by 99
Greenspan, S. L., Nelson, J. B., Trump, D. L., Wagner, J. M., Miller, M. E., Perera, S., & Resnick, N. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1233 · Cited by 85
Dong, H. V., Cortés, Y. I., Shiau, S., & Yin, M. T. (2014) · AIDS · doi:10.1097/qad.0000000000000363 · Cited by 83
The Importance of Previous Fracture Site on Osteoporosis Diagnosis and Incident Fractures in Women
Morin, S. N., Lix, L. M., & Leslie, W. D. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2204 · Cited by 80
Rosen, H. N., Vokes, T., Malabanan, A. O., Deal, C. L., Alele, J. D., Olenginski, T. P., & Schousboe, J. T. (2013) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2013.08.003 · Cited by 79
Shao, Y. J., Moore, D. F., Shih, W. J., Lin, Y., Jang, T. L., & Lu‐Yao, G. L. (2013) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11758.x · Cited by 71
Parkinson’s disease and osteoporosis
Vaserman, N. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.04.012 · Cited by 70
Safety issues and adverse reactions with osteoporosis management
Rossini, M., Adami, G., Adami, S., Viapiana, O., & Gatti, D. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1136287 · Cited by 70
Self-citationOnce‐Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture
Boonen, S., ORWOLL, E. S., Magaziner, J. S., Colon-Emeric, C. S., Adachi, J. D., Bucci-Rechtweg, C. M., Haentjens, P., Kaufman, J., Rizzoli, R., Vanderschueren, D., et al. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03666.x · Cited by 69
Osteoporosis after transplantation
Kulak, C. A. M., Borba, V. Z. C., Júnior, J. K., & Custódio, M. R. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0083-y · Cited by 67 · cited 2×
“Epidemiological data on organ transplant are less accurate, due to the relatively small number of patients included in available studies (67, 68).”
BackgroundHospers, I. C., van der Laan, J. G., Zeebregts, C. J., Nieboer, P., Wolffenbuttel, B. H. R., Dierckx, R. A. J. O., Kreeftenberg, H. G., Jager, P. L., & Slart, R. H. J. A. (2009) · Radiology · doi:10.1148/radiol.2513080887 · Cited by 66
Meta-Review: Adverse Effects of Inhaled Corticosteroids Relevant to Older Patients
Mattishent, K., Thavarajah, M., Blanco, P., Gilbert, D., Wilson, A. M., & Loke, Y. K. (2014) · Drugs · doi:10.1007/s40265-014-0202-z · Cited by 65
Giannini, S., Sella, S., Silva-Netto, F., Cattelan, C., Carbonare, L. D., Lazzarin, R., Marchini, F., Rigotti, P., Marcocci, C., Cetani, F., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091025 · Cited by 62
Self-citationFerrar, L., Jiang, G., Clowes, J. A., Peel, N. F. A., & Eastell, R. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070902 · Cited by 57
VARENNA, M., Bertoldo, F., Monaco, M., Giusti, A., Martini, G., Rossini, M., SIOMMMS, O. B. O., & Endorsed by, S. I. R. (2013) · Reumatismo · doi:10.4081/reumatismo.2013.143 · Cited by 54
Self-citationVertebral fracture assessment: impact of instrument and reader
Buehring, B., Krueger, D. C., Checovich, M. M., Gemar, D., Vallarta-Ast, N., Genant, H. K., & Binkley, N. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0972-4 · Cited by 54
Dose-Dependent Short-Term Effects of Single High Doses of Oral Vitamin D3 on Bone Turnover Markers
Rossini, M., Adami, S., Viapiana, O., Fracassi, E., Idolazzi, L., Povino, M. R., & Gatti, D. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9637-y · Cited by 51
Self-citationBone Mineral Density in Perimenopausal Women with Asthma: A Population-based Cross-sectional Study
Laatikainen, A. K., Kröger, H., Tukiainen, H. O., Honkanen, R., & Saarikoski, S. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9804084 · Cited by 51
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Clarke, B. L. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79521-4 · Cited by 51
Diacinti, D., Fiacco, R. D., Pisani, D., Todde, F., Cattaruzza, M. S., Diacinti, D., Arima, S., Romagnoli, E., Pepe, J., Cipriani, C., et al. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9643-0 · Cited by 50
Self-citationАдами, С., Bianchi, G., Brandi, M. L., Munno, O. D., Frediani, B., Gatti, D., Giannini, S., Girasole, G., Minisola, G., Minisola, S., et al. (2010) · PubMed · Cited by 48
Self-citationOfficial Positions for FRAX® Clinical Regarding Rheumatoid Arthritis
Broy, S. B., & Tanner, S. B. (2011) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2011.05.012 · Cited by 47
Bouvard, B., Hoppé, E., Soulié, P., Georgin-Mège, M., Jadaud, E., Abadie‐Lacourtoisie, S., Manac’h, A. P. L., Laffitte, A., Levasseur, R., Audran, M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr356 · Cited by 47
Zaman, K., Thurlimann, B. J. K., Huober, J., Schönenberger, A., Pagani, O., Luthi, J., Simcock, M., Giobbie‐Hurder, A., Berthod, G., Genton, C. Y., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr448 · Cited by 46
Król, C., Dekkers, O. M., Kroon, H. M. J. A., Rabelink, T. J., van Hoek, B., & Hamdy, N. A. T. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2214 · Cited by 44
Systematic vertebral fracture assessment in asymptomatic postmenopausal women
Maghraoui, A. E., Rezqi, A., Mounach, A., Achemlal, L., Bezza, A., & Ghozlani, I. (2012) · Bone · doi:10.1016/j.bone.2012.09.023 · Cited by 43
Reliability of Vertebral Fractures Assessment (VFA) in Children with Osteogenesis Imperfecta
Diacinti, D., Pisani, D., D'Avanzo, M., Celli, M., Zambrano, A., Stoppo, M., Diacinti, D., Roggini, M., Todde, F., D’Eufemia, P., et al. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-9960-1 · Cited by 41
Self-citationInhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Fong, K. M., & Black, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991 · Cited by 37
Alendronate for the Treatment of Osteoporosis in Men
Adámi, S., Prizzi, R., & Colapietro, F. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1066-2 · Cited by 32
Yang, S., Chen, Q., Wei, H.-K., Zhang, F., Yang, D., Shen, Y., & Ding, W. (2015) · PubMed · Cited by 29
Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy
Heffernan, M. P., Saag, K. G., Robinson, J. K., & Callen, J. P. (2006) · JAMA · doi:10.1001/jama.295.11.1300 · Cited by 27
Bonaccorsi, G., Fila, E., Cervellati, C., et al. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0009-2 · Cited by 26
Densitometric Threshold and Vertebral Fractures in Heart Transplant Patients
Carbonare, L. D., Zanatta, M., Braga, V., Sella, S., Vilei, M. T., Feltrin, G., Gambino, A., Pepe, I., Rossini, M., Adami, S., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31821cdeef · Cited by 24
Self-citationBazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms
Mirkin, S., Ryan, K. A., Chandran, A., & Komm, B. S. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.10.009 · Cited by 23
Rossini, M., Lello, S., Sblendorio, Viapiana, O., Fracassi, E., Adami, & Gatti, D. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s47807 · Cited by 23
Self-citationValera, M., Gourdy, P., Trémollières, F., & Arnal, J. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.07.012 · Cited by 23
Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
Kwan, M. L., Lo, J. C.-M., Tang, L., Laurent, C. A., Roh, J. M., Chandra, M., Hahn, T., Hong, C., Sucheston‐Campbell, L. E., Hershman, D. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111477 · Cited by 20
Sharifi, M., & Lewiecki, E. M. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.893819 · Cited by 19
Bone Disease in Organ Transplant Patients: Pathogenesis and Management
Chauhan, V., Ranganna, K. M., Chauhan, N., Vaid, M., & Kelepouris, E. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.05.2551 · Cited by 18
Risk of Fracture and the Concomitant Use of Bisphosphonates With Osteoporosis-Inducing Medications
Nyandege, A. N., Slattum, P. W., & Harpe, S. E. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015569594 · Cited by 16
Adami, S., Bertoldo, F., Gatti, D., Minisola, G., Rossini, M., SINIGAGLIA, L., & VARENNA, M. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9748-0 · Cited by 15
Self-citationBisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros
Rossini, M., Orsolini, G., Viapiana, O., Adami, S., & Gatti, D. (2015) · Endocrine · doi:10.1007/s12020-014-0506-5 · Cited by 14
Self-citationVitamin D and rheumatic diseases
Rossini, M., Gatti, D., Viapiana, O., Caimmi, C., Idolazzi, L., Fracassi, E., & Adámi, S. (2014) · Reumatismo · doi:10.4081/reumatismo.2014.788 · Cited by 10
Self-citation
Cited by
The Effectiveness of Physical Exercise on Bone Density in Osteoporotic Patients
Benedetti, M. G., Furlini, G., Zati, A., & Letizia Mauro, G. (2018) · BioMed Research International · doi:10.1155/2018/4840531 · Cited by 395
Osteoporosis: current concepts
Akkawi, I., & Zmerly, H. (2018) · Joints · doi:10.1055/s-0038-1660790 · Cited by 368
Guidelines for the management of osteoporosis and fragility fractures
Nuti, R., Brandi, M. L., Checchia, G., Di Munno, O., Dominguez, L., Falaschi, P., Fiore, C. E., Iolascon, G., Maggi, S., Michieli, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1874-2 · Cited by 328
Self-citationAdvances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.12956 · Cited by 265
Voulgaridou, G., Papadopoulou, S. K., Detopoulou, P., Tsoumana, D., Giaginis, C., Kondyli, F. S., Lymperaki, E., & Pritsa, A. (2023) · Diseases · doi:10.3390/diseases11010029 · Cited by 135
“The risk of OF results from a combination of factors that act mainly through the reduction in bone mineral density (BMD), as well as from factors that are completely or partially independent of it [1].”
Influential
Metadata
- Authors
- Rossini, M., Adami, S., Bertoldo, F., Diacinti, D., Gatti, D., Giannini, S., Giusti, A., Malavolta, N., Minisola, S., Osella, G., Pedrazzoni, M., Sinigaglia, L., Viapiana, O., & Isaia, G. C.
- Venue
- Reumatismo
- Publisher
- PAGEPress Publications
- Published
- 2016-06-23
- Volume
- 68
- Issue
- 1
- Pages
- 1-39
- ISSN
- 0048-7449 (ISSN-L)
- 2240-2683
- OpenAlex
- W1990714410
- Cited by
- 272
- References
- 110
- FWCI
- 24.58
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.